FEMYNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
FEMASYS INC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$1.63−0.02 (-1.21%)
Close on Oct 19, 2026
- Market cap
- $5.47M
- P/E (TTM)
- –
- Dividend yield
- –
FEMASYS INC revenue by segment
By business segment
By product or service
By region
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|
| United States | $1.39M | $1.07M | $1.01M | – | – | – | 60.8% | +29.8% |
| International [Member] | $899.76K | $555.60K | $58.05K | – | – | – | 39.2% | +61.9% |
From the segment and revenue-disaggregation notes of Femasys's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.